A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration

Recombinant Membrane-targeted Form of CD59 Inhibits the Growth of Choroidal Neovascular Complex in Mice

(2010) Nalini S. Bora et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Absence of Systemic Immune Response to Adenovectors After Intraocular Administration to Children With Retinoblastoma

(2010) Cristhian J Ildefonso et al.   MOLECULAR THERAPY

Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration

(2010) Timothy K MacLachlan et al.   MOLECULAR THERAPY

Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule

(2010) Michael Lukason et al.   MOLECULAR THERAPY

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited

(2009) Don H. Anderson et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors

(2008) D M Appledorn et al.   GENE THERAPY

Ocular gene therapy: current progress and future prospects

(2008) Pasqualina Colella et al.   TRENDS IN MOLECULAR MEDICINE